Robert LeBoyer
Stock Analyst at Noble Capital Markets
(1.20)
# 3,763
Out of 5,242 analysts
18
Total ratings
31.25%
Success rate
-0.26%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Robert LeBoyer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNXP Tonix Pharmaceuticals Holding | Reiterates: Outperform | $70 | $14.00 | +400.00% | 2 | Mar 20, 2025 | |
| NTRB Nutriband | Initiates: Outperform | $13 | $3.49 | +272.49% | 1 | Jan 22, 2025 | |
| GOVX GeoVax Labs | Maintains: Outperform | $150 → $250 | $2.75 | +8,990.91% | 2 | Aug 19, 2024 | |
| UNCY Unicycive Therapeutics | Initiates: Outperform | $60 | $7.63 | +686.37% | 1 | Feb 14, 2024 | |
| CVKD Cadrenal Therapeutics | Initiates: Outperform | $60 | $5.17 | +1,060.54% | 1 | Dec 18, 2023 | |
| ELDN Eledon Pharmaceuticals | Initiates: Outperform | $10 | $3.89 | +157.07% | 1 | Sep 27, 2023 | |
| MAIA MAIA Biotechnology | Initiates: Outperform | $14 | $1.28 | +993.75% | 1 | Feb 21, 2023 | |
| LCTX Lineage Cell Therapeutics | Initiates: Outperform | $8 | $1.32 | +506.06% | 2 | Aug 19, 2021 | |
| PSTV Plus Therapeutics | Initiates: Buy | $3,000 | $6.89 | +43,441.36% | 1 | Jan 25, 2021 | |
| BNTC Benitec Biopharma | Downgrades: Neutral | n/a | $11.40 | - | 1 | Oct 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $2.71 | +342.80% | 1 | Sep 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9,900,000 | $5.05 | +196,039,503.96% | 1 | Aug 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $34.72 | - | 1 | Apr 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $2.30 | +552.17% | 2 | Mar 8, 2018 |
Tonix Pharmaceuticals Holding
Mar 20, 2025
Reiterates: Outperform
Price Target: $70
Current: $14.00
Upside: +400.00%
Nutriband
Jan 22, 2025
Initiates: Outperform
Price Target: $13
Current: $3.49
Upside: +272.49%
GeoVax Labs
Aug 19, 2024
Maintains: Outperform
Price Target: $150 → $250
Current: $2.75
Upside: +8,990.91%
Unicycive Therapeutics
Feb 14, 2024
Initiates: Outperform
Price Target: $60
Current: $7.63
Upside: +686.37%
Cadrenal Therapeutics
Dec 18, 2023
Initiates: Outperform
Price Target: $60
Current: $5.17
Upside: +1,060.54%
Eledon Pharmaceuticals
Sep 27, 2023
Initiates: Outperform
Price Target: $10
Current: $3.89
Upside: +157.07%
MAIA Biotechnology
Feb 21, 2023
Initiates: Outperform
Price Target: $14
Current: $1.28
Upside: +993.75%
Lineage Cell Therapeutics
Aug 19, 2021
Initiates: Outperform
Price Target: $8
Current: $1.32
Upside: +506.06%
Plus Therapeutics
Jan 25, 2021
Initiates: Buy
Price Target: $3,000
Current: $6.89
Upside: +43,441.36%
Benitec Biopharma
Oct 5, 2020
Downgrades: Neutral
Price Target: n/a
Current: $11.40
Upside: -
Sep 28, 2020
Initiates: Buy
Price Target: $12
Current: $2.71
Upside: +342.80%
Aug 24, 2020
Initiates: Buy
Price Target: $9,900,000
Current: $5.05
Upside: +196,039,503.96%
Apr 10, 2018
Downgrades: Neutral
Price Target: n/a
Current: $34.72
Upside: -
Mar 8, 2018
Initiates: Buy
Price Target: $15
Current: $2.30
Upside: +552.17%